Janus kinase 1

From WikiMD's WELLNESSPEDIA

Janus kinase 1 (JAK1) is a member of the Janus kinase family of non-receptor tyrosine kinases. JAK1 plays a crucial role in the signaling pathways of various cytokines and growth factors, which are essential for the regulation of immune responses, hematopoiesis, and cell growth.

Structure[edit]

JAK1 is composed of several functional domains, including a Ferm domain, an SH2 domain, and a kinase domain. The kinase domain is responsible for the enzyme's catalytic activity, while the other domains are involved in protein-protein interactions and the regulation of kinase activity.

Function[edit]

JAK1 is involved in the signaling pathways of multiple cytokines, including interferons, interleukins, and growth hormones. Upon cytokine binding to its receptor, JAK1 is activated through phosphorylation. Activated JAK1 then phosphorylates signal transducer and activator of transcription (STAT) proteins, which translocate to the cell nucleus to modulate the expression of target genes.

Clinical Significance[edit]

Mutations in the JAK1 gene have been associated with various hematologic malignancies and immune disorders. Inhibitors targeting JAK1 are being developed and tested for the treatment of conditions such as rheumatoid arthritis, psoriasis, and certain types of cancer.

Related Kinases[edit]

JAK1 is closely related to other members of the Janus kinase family, including JAK2, JAK3, and TYK2. These kinases share similar structures and functions but are involved in different signaling pathways and physiological processes.

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.